James L Netterville
Overview
Explore the profile of James L Netterville including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1400
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hartmann H, Loberg M, Xu G, Schwarzkopf A, Chen S, Phifer C, et al.
Endocrinology
. 2025 Feb;
166(3).
PMID: 39951495
Tenascin-C (TNC) is a secreted extracellular matrix protein that is highly expressed during embryonic development and re-expressed during wound healing, inflammation, and neoplasia. Studies in developmental models suggest that TNC...
2.
Loberg M, Xu G, Chen S, Chen H, Wahoski C, Caroland K, et al.
bioRxiv
. 2025 Jan;
PMID: 39829764
Thyroid cancer progression from curable well-differentiated thyroid carcinoma to highly lethal anaplastic thyroid carcinoma is distinguished by tumor cell de-differentiation and recruitment of a robust stromal infiltrate. Combining an integrated...
3.
Aweeda M, Fassler C, Perez A, Miller A, Prasad K, Sharif K, et al.
J Pathol Inform
. 2024 Dec;
15:100404.
PMID: 39640916
Background: Positive margins are frequently observed in total laryngectomy (TL) specimens. Effective communication of margin sampling sites and final margin status between surgeons and pathologists is crucial. In this study,...
4.
Hartmann H, Loberg M, Xu G, Schwarzkopf A, Chen S, Phifer C, et al.
bioRxiv
. 2024 Nov;
PMID: 39574628
Tenascin-C (TNC) is a secreted extracellular matrix protein that is highly expressed during embryonic development and re-expressed during wound healing, inflammation, and neoplasia. Studies in developmental models suggest that TNC...
5.
Diaz D, Bergdorf K, Loberg M, Phifer C, Xu G, Sheng Q, et al.
Endocrine
. 2024 May;
86(1):114-118.
PMID: 38806891
Background: Anaplastic thyroid carcinoma (ATC) is a highly aggressive malignancy that has consistently shown Wnt/β-catenin (canonical) signaling activation in various study populations. There are currently no targetable treatments for BRAF-wildtype...
6.
Xu G, Loberg M, Gallant J, Sheng Q, Chen S, Lehmann B, et al.
Cell Genom
. 2023 Oct;
3(10):100409.
PMID: 37868034
Genomic and transcriptomic analysis has furthered our understanding of many tumors. Yet, thyroid cancer management is largely guided by staging and histology, with few molecular prognostic and treatment biomarkers. Here,...
7.
Ye W, Guo K, Gallant J, Stevens M, Weiss V, Bendfeldt G, et al.
Am J Otolaryngol
. 2023 Oct;
45(1):104068.
PMID: 37832328
Purpose: To examine the relationship between comorbidities and the development of immediate post-operative complications in patients undergoing oral cavity composite resection (OCCR) with free flap (FF) reconstruction. Materials And Methods:...
8.
Miller A, Prasad K, Sharif K, Adams D, Garbow L, Roberts E, et al.
Laryngoscope
. 2023 Jul;
134(1):191-197.
PMID: 37466329
Objectives: Virtual 3D specimen mapping of oncologic surgical specimens provides a visual record of the specimen and margin sampling sites which can be utilized in a variety of cancer care...
9.
Tierney W, Huang L, Chen S, Berry L, Anderson C, Amin M, et al.
Otolaryngol Head Neck Surg
. 2023 Mar;
168(6):1570-1575.
PMID: 36939627
The North American Airway Collaborative (NoAAC) previously published a 3-year multi-institutional prospective cohort study showing variation in treatment effectiveness between 3 primary surgical techniques for idiopathic subglottic stenosis (iSGS). In...
10.
Stone A, Powell M, Hamers K, Fletcher K, Francis D, Courey M, et al.
Laryngoscope Investig Otolaryngol
. 2022 Oct;
7(5):1499-1505.
PMID: 36262464
Objective: The purpose of this study was to quantitatively compare the effectiveness of unilateral and bilateral botulinum toxin A (BTX-A) injections for mitigating undesirable weak/breathy voice quality and dysphagia for...